Live feed
Filing
SC 13G/A
SC 13G/A0001213900-24-011455·Brio Capital Master Fund Ltd.
Schedule 13G ownership disclosure
Sigyn Therapeutics Inc
Security class unavailable · CUSIP: 82674U205
Event date: 2024-01-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-011455
- Form type
- SC 13G/A
- Filer
- Brio Capital Master Fund Ltd.
- CIK
- CIK 1560894
- Filed
- Feb 08, 2024
- Reporting period
- Jan 09, 2024
- Description
- Schedule 13G beneficial ownership